Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Infection Risk Up in Month After CAR T-Cell Immunotherapy
FRIDAY, May 29, 2020 (HealthDay News) — For children and young adults receiving CD19 chimeric antigen receptor (CAR) T-cell infusion (CTI), infection rates increase in the first month after treatment and then decrease, according to a study published in the May issue of Open Forum Infectious Diseases.
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
FRIDAY, May 29, 2020 (HealthDay News) — For adolescent and young adult (AYA) patients with Hodgkin lymphoma (HL), treatment strategies differ, but outcomes are equivalent with treatment at pediatric and adult centers, according to a study published online May 22 in Cancer Medicine.
Links Found Between Leaders of Medical Associations, Industry
THURSDAY, May 28, 2020 (HealthDay News) — There are extensive financial relationships between leaders of U.S. professional medical associations and industry, according to a study published online May 27 in The BMJ.
Risk for Later Invasive Breast Cancer Up for Women With DCIS
THURSDAY, May 28, 2020 (HealthDay News) — Women with screening-detected ductal carcinoma in situ (DCIS) have increased long-term risks for invasive breast cancer and breast cancer death, according to a study published online May 27 in The BMJ.
9.5 Percent Uninsured in U.S. From January Through June 2019
WEDNESDAY, May 27, 2020 (HealthDay News) — A total of 9.5 percent of persons were uninsured from January through June 2019, according to a report published online May 28 by the National Center for Health Statistics.
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity to conduct telehealth-based outpatient visits, while only one in four had tele-intensive care unit (tele-ICU) capabilities, according to a research letter published online April 30 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Early Informed Lung Cancer Patients Have Greater Survival Rates
WEDNESDAY, May 27, 2020 (HealthDay News) — Lung cancer patients who are given the opportunity to be informed of their diagnosis have a longer median survival time, according to a study published in the May issue of Psycho-Oncology.
Abstract/Full Text (subscription or payments may be required)
Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Few Young Adults Receive Palliative Care as Part of Advanced Cancer Treatment 
Emergency Presentation of Cancer Common in Older Adults .jpg)
Remote Patient-Reported Outcome Monitoring Empowers Patients With Cancer 
Tobacco Treatment Program Effective in Oncology Settings 
Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients 
